Literature DB >> 2565118

Beta-adrenoceptors and human skeletal muscle characterisation of receptor subtype and effect of age.

M S Elfellah1, R Dalling, I M Kantola, J L Reid.   

Abstract

1. Rectus abdominis muscle biopsies were obtained from 28 patients undergoing abdominal surgery. In membranes prepared from these biopsies beta-adrenoceptor binding was examined. The apparent affinity (KD) and the density (Bmax) of the receptors for the radioligand (-)-[125I]cyanopindolol were 28.5 +/- 2.7 (pM) and 25.9 +/- 2.1 (fmol mg-1 protein) (mean +/- s.e. mean) respectively. In forceps biopsies from vastus lateralis muscle from four healthy volunteers the values for KD and Bmax were 22.5 +/- 4.4 (pM) and 16.4 +/- 2.2 (fmol mg-1 protein). The binding characteristics for the radioligand were similar in the biopsies from the two muscle sites. 2. Inhibition of the radioligand binding by the selective beta 2-adrenoceptor antagonist ICI 118551 (KI = 117 +/- 45 nM) and selective beta 1-adrenoceptor antagonist metoprolol (KI = 15229 +/- 5046 nM) suggests the dominance of beta 2-adrenoceptor subtype in human skeletal muscle. 3. There were no significant differences in the skeletal muscle beta-adrenoceptor densities or affinities between the young and older patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565118      PMCID: PMC1379702          DOI: 10.1111/j.1365-2125.1989.tb05332.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  35 in total

1.  The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat.

Authors:  W C BOWMAN; E ZAIMIS
Journal:  J Physiol       Date:  1958-11-10       Impact factor: 5.182

2.  Comparison of beta adrenergic receptor subtypes in mammalian tissues.

Authors:  K P Minneman; A Hedberg; P B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

Review 3.  The role of skeletal muscle beta-adrenoreceptors in the regulation of plasma potassium.

Authors:  M S Elfellah; J L Reid
Journal:  J Auton Pharmacol       Date:  1987-06

4.  Cyclic AMP in skeletal muscle.

Authors:  S E Mayer; J T Stull
Journal:  Ann N Y Acad Sci       Date:  1971-12-30       Impact factor: 5.691

5.  Alterations in leukocyte beta-receptor affinity with aging. A potential explanation for altered beta-adrenergic sensitivity in the elderly.

Authors:  R D Feldman; L E Limbird; J Nadeau; D Robertson; A J Wood
Journal:  N Engl J Med       Date:  1984-03-29       Impact factor: 91.245

6.  Coronary artery syndromes after sudden propranolol withdrawal.

Authors:  E L Alderman; D J Coltart; G E Wettach; D C Harrison
Journal:  Ann Intern Med       Date:  1974-11       Impact factor: 25.391

7.  Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.

Authors:  A Hedberg; J G Gerber; A S Nies; B B Wolfe; P B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

8.  Development of "resistance" in beta-adrenergic receptors of asthmatic patients.

Authors:  N L Svedmyr; S A Larsson; G K Thiringer
Journal:  Chest       Date:  1976-04       Impact factor: 9.410

9.  The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man.

Authors:  A D Struthers; J L Reid; R Whitesmith; J C Rodger
Journal:  Clin Sci (Lond)       Date:  1983-08       Impact factor: 6.124

10.  Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.

Authors:  O E Brodde; X L Wang; N O'Hara; A Daul; W Schiess
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

View more
  15 in total

1.  Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.

Authors:  B J Lipworth; B F Tregaskis; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Beta-adrenoceptor responses to inhaled salbutamol in the elderly.

Authors:  B J Lipworth; B F Tregaskis; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

3.  Affinity of clenbuterol analogues for beta 2-adrenoceptors in bovine skeletal muscle and the effect of these compounds on urinary nitrogen excretion in female rats.

Authors:  M N Sillence; G G Pegg; D B Lindsay
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

4.  Muscle metaboreflex activation during dynamic exercise evokes epinephrine release resulting in β2-mediated vasodilation.

Authors:  Jasdeep Kaur; Marty D Spranger; Robert L Hammond; Abhinav C Krishnan; Alberto Alvarez; Robert A Augustyniak; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-24       Impact factor: 4.733

5.  Acute exposure of primary rat soleus muscle to zilpaterol HCl (β2 adrenergic agonist), TNFα, or IL-6 in culture increases glucose oxidation rates independent of the impact on insulin signaling or glucose uptake.

Authors:  Caitlin N Cadaret; Kristin A Beede; Hannah E Riley; Dustin T Yates
Journal:  Cytokine       Date:  2017-04-05       Impact factor: 3.861

6.  Adrenergic stimulated skeletal muscle glycogenolysis in perfused hindlimbs of young and old male Fischer 344 rats.

Authors:  L M Larkin; B A Horwitz; K C Eiffert; R B McDonald
Journal:  Am J Physiol       Date:  1994-03

Review 7.  Physiological changes due to age. Implications for cardiovascular drug therapy.

Authors:  I Stolarek; P J Scott; F I Caird
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

8.  Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.

Authors:  B Tomlinson; J M Cruickshank; Y Hayes; J C Renondin; J B Lui; B R Graham; A Jones; A D Lewis; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

9.  Adenosine/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity.

Authors:  Thorsten Gnad; Gemma Navarro; Minna Lahesmaa; Laia Reverte-Salisa; Francesca Copperi; Arnau Cordomi; Jennifer Naumann; Aileen Hochhäuser; Saskia Haufs-Brusberg; Daniela Wenzel; Frank Suhr; Naja Zenius Jespersen; Camilla Scheele; Volodymyr Tsvilovskyy; Christian Brinkmann; Joern Rittweger; Christian Dani; Mathias Kranz; Winnie Deuther-Conrad; Holger K Eltzschig; Tarja Niemi; Markku Taittonen; Peter Brust; Pirjo Nuutila; Leonardo Pardo; Bernd K Fleischmann; Matthias Blüher; Rafael Franco; Wilhelm Bloch; Kirsi A Virtanen; Alexander Pfeifer
Journal:  Cell Metab       Date:  2020-06-25       Impact factor: 27.287

10.  In vitro effects of Beta-2 agonists on skeletal muscle differentiation, hypertrophy, and atrophy.

Authors:  Francesca Wannenes; Loretta Magni; Matteo Bonini; Ivan Dimauro; Daniela Caporossi; Costanzo Moretti; Sergio Bonini
Journal:  World Allergy Organ J       Date:  2012-06       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.